Bionics

Exoskeleton Market Size to Exceed to USD 20.3 Billion By 2035 Says, Roots Analysis

Retrieved on: 
Tuesday, January 9, 2024

LONDON, Jan. 9, 2024 /PRNewswire/ -- 

Key Points: 
  • Despite the market restraints, growth factors propelling the exoskeleton market include increased research on robotic exoskeletons to help patients with mobility impairment.
  • Additionally, the rising government initiatives and collaboration between global exoskeleton market players drive the market during the forecast period.
  • Based on the mode of operation, the exoskeleton market is segmented into powered exoskeleton, passive exoskeleton, and hybrid exoskeleton.
  • Based on key geographical regions, the exoskeleton market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World
    North America will lead the global exoskeleton market, capturing 38.2% of the market share by 2035.

Exoskeleton Market Size to Exceed to USD 20.3 Billion By 2035 Says, Roots Analysis

Retrieved on: 
Tuesday, January 9, 2024

LONDON, Jan. 9, 2024 /PRNewswire/ -- 

Key Points: 
  • Despite the market restraints, growth factors propelling the exoskeleton market include increased research on robotic exoskeletons to help patients with mobility impairment.
  • Additionally, the rising government initiatives and collaboration between global exoskeleton market players drive the market during the forecast period.
  • Based on the mode of operation, the exoskeleton market is segmented into powered exoskeleton, passive exoskeleton, and hybrid exoskeleton.
  • Based on key geographical regions, the exoskeleton market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World
    North America will lead the global exoskeleton market, capturing 38.2% of the market share by 2035.

Ekso Bionics Launches GaitCoach Software for EksoNR

Retrieved on: 
Monday, January 8, 2024

SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the launch of GaitCoach™, its next generation gait therapy software for EksoNR.

Key Points: 
  • SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the launch of GaitCoach™, its next generation gait therapy software for EksoNR.
  • GaitCoach is a comprehensive gait therapy software that supports a broad spectrum of patients who use EksoNR.
  • GaitCoach will replace SmartAssist, the software that has been in use since 2016 and was optimized in 2019 with the launch of EksoNR.
  • “By listening to the feedback of physical therapists, clinicians and patients, Ekso Bionics has elevated EksoNR with GaitCoach, a new software solution designed to further improve patient rehabilitation,” said Scott Davis, Chief Executive Officer of Ekso Bionics.

MAHLE at CES 2024: A System Champion for E-Mobility

Retrieved on: 
Thursday, January 4, 2024

With its bionic battery-cooling plate, MAHLE has achieved a technological leap forward by using nature as a model.

Key Points: 
  • With its bionic battery-cooling plate, MAHLE has achieved a technological leap forward by using nature as a model.
  • The company's all-new positioning system for wireless charging was recently chosen as the global standard technology by SAE International.
  • MAHLE's technology kit for electric motors featured at CES 2024 combines the advantages of the company's benchmark SCT and MCT electric motors.
  • SAE International, the US-based standards developing organization for engineering professionals, has chosen the MAHLE positioning system as the global standard solution for wireless charging.

Kanama Smart Bait: A Breakthrough in Intelligent Fishing Technology

Retrieved on: 
Sunday, December 31, 2023

SHINJUKU-KU, Tokyo, Dec. 31, 2023 /PRNewswire-PRWeb/ -- As we all know, if you want to catch big fish, using live fish as bait is the best choice, but live bait fish is not easy to get and not well preserved, and it is easy to lose activity during the fishing process, especially in the deep sea which is often hundreds of meters. Kanama smart bait from Japan is a good solution to this problem.

Key Points: 
  • Kanama smart bait from Japan is a good solution to this problem.
  • Kanama smart bait from Japan is a good solution to this problem.
  • Anglers only need to insert the smart bait from the mouth of the fish into the belly of the dead fish.
  • Kanama smart bait works even at depths of up to 300 meters.

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

Retrieved on: 
Tuesday, December 12, 2023

SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has completed its review of the Ekso Indego Personal and approved use of Healthcare Common Procedure Coding System (“HCPCS”) Code K1007 to bill Medicare for such device.

Key Points: 
  • SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has completed its review of the Ekso Indego Personal and approved use of Healthcare Common Procedure Coding System (“HCPCS”) Code K1007 to bill Medicare for such device.
  • “We are very pleased that CMS recognizes the potential health benefits that exoskeletons like our Ekso Indego Personal can have on the daily lives of individuals with spinal cord injuries (“SCIs”),” said Scott Davis, Chief Executive Officer of Ekso Bionics.
  • “Once the reimbursement code takes effect, we expect that our Ekso Indego Personal will be accessible to those eligible within the SCI community at a substantially lower cost.
  • The device contains an advanced gait mode where the individual can reach faster walking speeds, granting them a new level of independence.

American Institute of Chemical Engineers Honors Organizations and Leaders for Empowering Possibilities

Retrieved on: 
Monday, December 11, 2023

NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE) celebrated the contributions of the companies and the leaders of AdvanSix Inc. and Air Products, and showcased the good works of chemical engineers and their employers, at the 2023 AIChE Gala, held December 7 in New York City.

Key Points: 
  • NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The American Institute of Chemical Engineers (AIChE) celebrated the contributions of the companies and the leaders of AdvanSix Inc. and Air Products, and showcased the good works of chemical engineers and their employers, at the 2023 AIChE Gala, held December 7 in New York City.
  • The award for AdvanSix was accepted by Erin Kane, the company’s President and Chief Executive Officer.
  • In accepting the award at the gala, Kane shared “AdvanSix is grounded in our focus on good chemistry.
  • Mitragotri thanked the AIChE foundation for recognizing drug delivery as a prominent contribution of chemical engineers to the field of medicine.

Global Microneedle Market 2023-2028 - Market Poised for Significant Expansion by 2028 to Reach $1.3 Billion with Focus on Dermatology and Disease Diagnosis - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 28, 2023

The global market for microneedles was valued at $1.0 billion in 2023.

Key Points: 
  • The global market for microneedles was valued at $1.0 billion in 2023.
  • This market is anticipated to reach $1.3 billion by the end of 2028, growing at a CAGR of 5.1% from 2023 through 2028.
  • Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications.
  • The report also covers market projections for 2028 and includes the market rankings of key market players.

2023 Design Intelligence Award Held at China Academy of Art

Retrieved on: 
Thursday, December 21, 2023

HANGZHOU, China, Dec. 21, 2023 /PRNewswire/ -- The 2023 Design Intelligence Award (DIA) ceremony series events, including an exhibition, a conference, launch of DIU (Design Intelligence Union) Headquarters (Shanghai), and debut of "DIA Project", took place from December 14 to 15 at the Liangzhu Campus of the China Academy of Art (CAA).

Key Points: 
  • HANGZHOU, China, Dec. 21, 2023 /PRNewswire/ -- The 2023 Design Intelligence Award (DIA) ceremony series events, including an exhibition, a conference, launch of DIU (Design Intelligence Union) Headquarters (Shanghai), and debut of "DIA Project", took place from December 14 to 15 at the Liangzhu Campus of the China Academy of Art (CAA).
  • DIA is China's first international academic competition in industrial design jointly launched by the People's Government of Zhejiang Province and CAA.
  • With many years of development, DIA has become the most influential industrial design competition in China, which is professional, international and forward-looking, as well as an important platform for the global design community to explore design intelligence.
  • The 2023 DIA was launched on March 12, 2023 and received more than 7,000 entries from 41 countries and regions.

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

Retrieved on: 
Thursday, November 16, 2023

SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid Services’ (“CMS”) Healthcare Common Procedure Coding System (“HCPCS”) public meeting on November 29, 2023, to discuss appropriate Medicare payment for the Ekso Indego Personal.

Key Points: 
  • SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid Services’ (“CMS”) Healthcare Common Procedure Coding System (“HCPCS”) public meeting on November 29, 2023, to discuss appropriate Medicare payment for the Ekso Indego Personal.
  • “We appreciate CMS for providing Ekso with this opportunity to highlight the urgent need of the Ekso Indego Personal for thousands of individuals with a spinal cord injury (“SCI”),” said Scott Davis, Chief Executive Officer of Ekso Bionics.
  • “The Home Health Prospective Payment System Rule, finalized earlier this month, has significantly increased interest in our personal, home and community use exoskeleton.
  • Ekso Indego Personal is a modular, lightweight and easily portable exoskeleton that is safe for use in most home and community environments.